Cargando…
A fluorescence-based assay for Trichomonas vaginalis drug screening
BACKGROUND: The emergence and spread of drug resistance in Trichomonas vaginalis parasites has become an important concern in trichomoniasis treatment. Fast and reliable growth assessment is critical for validating in vitro drug susceptibility and high-throughput screening of newly developed drugs....
Autores principales: | Chen, Qianqian, Li, Jingzhong, Wang, Zhensheng, Meng, Wei, Wang, Heng, Wang, Zenglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507874/ https://www.ncbi.nlm.nih.gov/pubmed/37723582 http://dx.doi.org/10.1186/s13071-023-05919-6 |
Ejemplares similares
-
Comparison of Two PCR Assays for Trichomonas vaginalis
por: Noh, Chang-Suk, et al.
Publicado: (2019) -
Trichomonas vaginalis in Pregnancy
por: Faro, Sebastian
Publicado: (1994) -
In Silico and In Vitro Antimalarial Screening and Validation Targeting Plasmodium falciparum Plasmepsin V
por: Ji, Xin, et al.
Publicado: (2022) -
Spliceosomal introns in Trichomonas vaginalis revisited
por: Wang, Shuqi E., et al.
Publicado: (2018) -
Transcriptional profile of Trichomonas vaginalis in response to metronidazole
por: Xie, Yiting, et al.
Publicado: (2023)